[Molecular basis of familial hypercholesterolemia-like phenotype heterogeneity]

Area of Science:

• Genetics
• Cardiovascular Medicine
• Biochemistry

Background:

• Familial hypercholesterolemia (FH) is a genetic disorder characterized by high levels of low-density lipoprotein (LDL) cholesterol.
• Traditionally, mutations in the LDL receptor (LDL-R) gene were considered the sole cause of FH, leading to LDL-R dysfunction and premature cardiovascular disease.
• This genetic defect results in impaired clearance of LDL cholesterol from the bloodstream.

Purpose of the Study:

• To review recent research on the molecular basis of FH-like phenotype heterogeneity.
• To explore genetic factors beyond LDL-R mutations that contribute to FH-like conditions.
• To highlight the importance of understanding diverse genetic mechanisms in FH for improved diagnosis and treatment.

Main Methods:

• Literature review of recent studies on FH and FH-like phenotypes.
• Analysis of genetic mutations and their impact on LDL metabolism.
• Synthesis of evidence regarding novel genetic causes and their mechanisms.

Main Results:

• Evidence indicates that mutations in at least six additional genes, besides LDL-R, can result in an FH-like phenotype.
• These alternative genetic mutations operate through distinct molecular mechanisms.
• The identified genes contribute to the heterogeneity observed in FH-like conditions.

Conclusions:

• LDL-R mutations are not the only cause of FH phenotype; other genetic factors play a significant role.
• Further investigation into these genes is crucial for elucidating plasma LDL regulation.
• Understanding FH-like phenotype heterogeneity provides a molecular basis for targeted diagnosis and treatment strategies.